Clinical Trial Update: Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR [Phase 2]

View source ↗

Summary

A randomized, double-blind Phase IIb trial evaluated whether ketorolac mouth rinse, by inhibiting cyclooxygenase, affects oropharyngeal leukoplakia compared wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukoplakia
• Periodontal Disease

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Leukoplakia, Periodontal Disease | Phase 2 | Status: COMPLETED